XML 33 R24.htm IDEA: XBRL DOCUMENT v3.24.3
Investments in and Advances to Joint Ventures
9 Months Ended
Sep. 30, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Investments in and Advances to Joint Ventures
14.
Investments in and Advances to Joint Ventures

The Company participates in joint ventures to bid, negotiate and complete specific projects. The Company is required to consolidate these joint ventures if it holds the majority voting interest or if the Company meets the criteria under the consolidation model, as described below.

The Company performs an analysis to determine whether its variable interests give the Company a controlling financial interest in a Variable Interest Entity (“VIE”) for which the Company is the primary beneficiary and should,

therefore, be consolidated. Such analysis requires the Company to assess whether it has the power to direct the activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

The Company analyzed all of its joint ventures and classified them into two groups: (1) joint ventures that must be consolidated because they are either not VIEs and the Company holds the majority voting interest, or because they are VIEs and the Company is the primary beneficiary; and (2) joint ventures that do not need to be consolidated because they are either not VIEs and the Company holds a minority voting interest, or because they are VIEs and the Company is not the primary beneficiary.

Many of the Company’s joint venture agreements provide for capital calls to fund operations, as necessary; however, such funding is infrequent and is not anticipated to be material.

Letters of credit outstanding described in “Note 10 – Debt and Credit Facilities” that relate to project ventures are $162.7 million and $147.7 million at September 30, 2024 and December 31, 2023.

In the table below, aggregated financial information relating to the Company’s joint ventures is provided because their nature, risk and reward characteristics are similar. None of the Company’s current joint ventures that meet the characteristics of a VIE are individually significant to the consolidated financial statements.

Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Current assets

 

$

503,099

 

 

$

426,633

 

Noncurrent assets

 

 

10,894

 

 

 

14,295

 

Total assets

 

 

513,993

 

 

 

440,928

 

Current liabilities

 

 

307,612

 

 

 

260,286

 

Noncurrent liabilities

 

 

2,916

 

 

 

5,132

 

Total liabilities

 

 

310,528

 

 

 

265,418

 

Total joint venture equity

 

$

203,465

 

 

$

175,510

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

September 30, 2024

 

 

September 30, 2023

 

Revenue

 

$

193,461

 

 

$

185,602

 

 

$

582,209

 

 

$

514,339

 

Costs

 

 

165,873

 

 

 

160,423

 

 

 

500,308

 

 

 

445,829

 

Net income

 

$

27,588

 

 

$

25,179

 

 

$

81,901

 

 

$

68,510

 

Net income attributable to noncontrolling interests

 

$

13,638

 

 

$

12,364

 

 

$

40,428

 

 

$

33,617

 

 

The assets of the consolidated joint ventures are restricted for use only by the particular joint venture and are not available for the Company’s general operations.

Unconsolidated Joint Ventures

The Company accounts for its unconsolidated joint ventures using the equity method of accounting. Under this method, the Company recognizes its proportionate share of the net earnings of these joint ventures as “Equity in (losses) earnings of unconsolidated joint ventures” in the consolidated statements of income. The Company’s maximum exposure to loss as a result of its investments in unconsolidated joint ventures is typically limited to the aggregate of the carrying value of the investment and future funding commitments.

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

 

 

 

September 30, 2024

 

 

December 31, 2023

 

Current assets

 

$

1,675,165

 

 

$

1,607,953

 

Noncurrent assets

 

 

465,806

 

 

 

483,693

 

Total assets

 

 

2,140,971

 

 

 

2,091,646

 

Current liabilities

 

 

996,238

 

 

 

1,057,113

 

Noncurrent liabilities

 

 

496,097

 

 

 

518,647

 

Total liabilities

 

 

1,492,335

 

 

 

1,575,760

 

Total joint venture equity

 

$

648,636

 

 

$

515,886

 

Investments in and advances to unconsolidated joint ventures

 

$

194,524

 

 

$

128,204

 

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

September 30, 2024

 

 

September 30, 2023

 

Revenue

 

$

581,232

 

 

$

634,937

 

 

$

1,598,764

 

 

$

1,514,561

 

Costs

 

 

560,492

 

 

 

581,041

 

 

 

1,593,213

 

 

 

1,474,991

 

Net income (loss)

 

$

20,740

 

 

$

53,896

 

 

$

5,551

 

 

$

39,570

 

Equity in losses of unconsolidated joint ventures

 

$

872

 

 

$

10,262

 

 

$

(18,025

)

 

$

4,497

 

 

The Company had net contributions to its unconsolidated joint ventures for the three months ended September 30, 2024 and September 30, 2023 of $34.4 million and of $36.1 million, respectively and $83.7 million and $50.8 million for the nine months ended September 30, 2024 and September 30, 2023, respectively.

The following table presents certain financial statement impacts from changes in estimates which resulted in a write-down in a design build joint venture in the Critical Infrastructure segment (in thousands):

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2024

 

 

September 30, 2023

 

 

September 30, 2024

 

 

September 30, 2023

 

Operating income (loss)

 

$

(6,716

)

 

$

5,099

 

 

$

(37,509

)

 

$

(12,414

)

Net income (loss)

 

 

(4,936

)

 

 

3,799

 

 

 

(35,258

)

 

 

(9,248

)

Diluted income (loss) per share

 

$

(0.04

)

 

$

0.03

 

 

$

(0.33

)

 

$

(0.08

)